Stocks · Health care · Pharmaceutical Preparations

Xeris Biopharma Holdings, Inc.

XERS Clue Score53
United States Fiscal year ends December CIK 0001867096 Results filed 5 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Kevin McCulloch
2 Nov 2026
See Remarks
Sold on a plan
15,000
$10.23
$153.49K
Beth Hecht
2 Nov 2026
See Remarks
Sold on a plan
25,000
$10.23
$255.83K
Steven Pieper
2 Nov 2026
See Remarks
Sold on a plan
5,000
$10.23
$51.17K

What was left out

Form 4 filings counted 4
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 22,365
History held since 5 Oct 2021